Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives
Pharmacology & Therapeutics
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives. // Pharmacology & Therapeutics. – URL: https://www.sciencedirect.com/science/article/pii/S0163725826001336?dgcid=rss_sd_all
Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives. Pharmacology & Therapeutics. https://www.sciencedirect.com/science/article/pii/S0163725826001336?dgcid=rss_sd_all
“Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives.” Pharmacology & Therapeutics.
@article{article62302,
title = {Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives},
journal = {Pharmacology \& Therapeutics},
url = {https://www.sciencedirect.com/science/article/pii/S0163725826001336?dgcid=rss_sd_all}
}